Health Condition 1: C801- Malignant (primary) neoplasm, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Department of physiotherapy
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are about to begin chemotherapy will be recruited for the study. These patients will then be followed up after one month of chemotherapy to determine the presence of chemotherapy-induced peripheral neuropathy (CIPN).
Exclusion criteria
Exclusion criteria: Individuals who have been diagnosed with any other type of peripheral neuropathy (e.g., diabetic neuropathy), have a MOCA score of less than 24, are bedridden or wheelchair-bound, or have a history of neurological deficits such as stroke or seizures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fall risk and quality of life in cancer patients with chemotherapy-induced peripheral neuropathy. This will be assessed by the fall efficacy scale, EORTC CIPN-20, WHOQOL BREF, FACT GOGNtx-13 and functional tests like monofilament, vibration perception threshold test and timed up and go test.Timepoint: All these outcomes will be measured at 2 time points. Before the start of chemotherapy and after 1 month of chemotherapy once they get diagnosed with chemotherapy induced peripheral neuropathy | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical activity level in cancer patients with chemotherapy induced peripheral neuropathyTimepoint: Before the start of chemotherapy and after 1 month of chemotherapy once they get diagnosed with chemotherapy induced peripheral neuropathy | — |
Countries
India
Contacts
Public ContactMrs Nivedita S Prabhu
Manipal College of Health Professions (MCHP), Manipal Academy of Higher Education (MAHE)
Outcome results
None listed